Jean-Pierre Llanos

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Chronic Obstructive Pulmonary Disease

Systematic Review

Allergic Rhinitis

Top Venues

Advances in therapy

The European respiratory journal

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Stephanie Korn, Bill Cook, Lisa J Simpson, Jean-Pierre Llanos, Christopher S Ambrose
Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review. Advances in therapy (2023)
Jonathan A Bernstein, Jean-Pierre Llanos, Gillian Hunter, Neil Martin, Christopher S Ambrose
Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review. Advances in therapy (2023)
Jonathan Corren, Christopher E Brightling, Louis-Philippe Boulet, Celeste Porsbjerg, Michael E Wechsler, Andrew Menzies-Gow, Christopher S Ambrose, Bill Cook, Neil Martin, Joseph Spahn, Jean-Pierre Llanos
Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond. The European respiratory journal 61 (3) (2023)
Jonathan Corren, Christopher S Ambrose, Janet M Griffiths, Åsa Hellqvist, Andrew W Lindsley, Jean-Pierre Llanos, Gene Colice, Andrew Menzies-Gow
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)